Dicerna Pharmaceuticals, Inc., a leader in the development of RNAi therapeutics, today announced the presentation of new preclinical data on its Dicer substrate short interfering RNA (DsiRNA) therapeutics targeting MYC and â-catenin (CTNNB1) oncogenes in models of hepatocellular carcinoma (HCC) and colorectal cancer (CRC).
Celator Pharmaceuticals, Inc., a biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer, today announced the publication of Phase 2 data evaluating CPX-351 in adult patients with first-relapse acute myeloid leukemia (AML) in Cancer, a peer-reviewed journal of the American Cancer Society.
Sorrento Therapeutics, Inc., an oncology company developing new treatments for cancer and associated pain, announced today that over 80 patients randomized in the ongoing TRIBECA™ (TRIal establishing bioequivalence [BE] between Cynviloq™ and Albumin-bound paclitaxel*) registrational trial have been dosed. Sorrento intends to continue enrolling all qualified patients in the current screening process and anticipates having the "last patient in" by the end of January.
Researchers at Rensselaer Polytechnic Institute and Cornell University have devised a new nanoscale surface which uses an electrochemical anodization process in order to prevent the surface attachment of bacteria.
By Alexander Chilton
12 Jan 2015
OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced from the Consumer Electronics Show in Las Vegas, that it has partnered with Wavelens to bring to market an innovative autofocus (AF) technology that utilizes a microelectromechanical system (MEMS) instead of the dated voice coil motor (VCM) technology used in many consumer devices today.
Ju Li, the Battelle Energy Alliance Professor of Nuclear Science and Engineering and professor of materials science and engineering, has been named a fellow of the American Physical Society (APS). Nominated by the Division of Materials Physics, Li was cited “for seminal work on understanding the fundamental properties of ultra-strength materials and formulating the concept of elastic strain engineering.”
Precision NanoSystems, a leader in the development and application of microfluidics for the manufacture of nanomedicines; and, Arcturus Therapeutics, a leading small interfering RNA (siRNA) and messenger RNA (mRNA) drug discovery and development company, today announced a partnership for the manufacture of RNA medicines.
Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, and OnCore Biopharma, Inc., a biopharmaceutical company dedicated to discovering, developing and commercializing an all-oral cure for patients suffering from chronic hepatitis B virus (HBV) infection, announced today that they have agreed to merge to create a new leading global HBV company focused on developing a curative regimen for hepatitis B patients by combining multiple therapeutic approaches.
Persistence Market Research has released a new report about the global nano-enabled packaging market. The report, titled ‘Global Market Study on Nano-Enabled Packaging For Food and Beverages: Intelligent Packaging to Witness Highest Growth by 2020’, predicts that the nano-enabled packaging market will enjoy a healthy CAGR of 12.7% during the report’s forecast period of 2014-2020, and will expand from its 2013 market value of US$6.5 billion to US$15 billion in 2020.
Even when building big, every atom matters, according to new research on particle-based materials at Rice University.
A resilience to extreme conditions by the most transparent, lightweight and flexible material for conducting electricity could help revolutionise the electronic industry, according to a new study.
Biophotonic Solutions Inc. (BSI), the world leader in automated laser pulse compression, announces that its "MIIPS" automated pulse compression and shaping technology is playing a key role in scientific experiments at Michigan State University (MSU), where researchers in the Dantus Research Group are using novel ultrafast laser-based spectroscopy techniques to investigate molecular dynamics.
Research and Markets has announced the addition of the "Nanotechnology in Sustainable Energy - Visionary Outlook" report to their offering.
Sangamo BioSciences, Inc. announced that the company has in-licensed nanoparticle technology to enable systemic messenger RNA (mRNA) delivery of Sangamo's proprietary zinc finger nucleases (ZFNs). mRNA delivery of ZFNs is being used in the development of the next generation of Sangamo's ZFP Therapeutics®.
Nanoparticles, extremely tiny particles measured in billionths of a meter, are increasingly everywhere, and especially in biomedical products. Their toxicity has been researched in general terms, but now a team of Israeli scientists has for the first time found that exposure nanoparticles (NPs) of silicon dioxide (SiO2) can play a major role in the development of cardiovascular diseases when the NP cross tissue and cellular barriers and also find their way into the circulatory system.